These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

555 related articles for article (PubMed ID: 34526087)

  • 121. Breakthrough invasive fungal disease in patients receiving posaconazole primary prophylaxis: a 4-year study.
    Lerolle N; Raffoux E; Socie G; Touratier S; Sauvageon H; Porcher R; Bretagne S; Bergeron A; Azoulay E; Molina JM; Lafaurie M
    Clin Microbiol Infect; 2014 Nov; 20(11):O952-9. PubMed ID: 24861577
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Challenges in Diagnosing COVID-19-Associated Pulmonary Aspergillosis in Critically Ill Patients: The Relationship between Case Definitions and Autoptic Data.
    Casalini G; Giacomelli A; Galimberti L; Colombo R; Ballone E; Pozza G; Zacheo M; Galimberti M; Oreni L; Carsana L; Longo M; Gismondo MR; Tonello C; Nebuloni M; Antinori S
    J Fungi (Basel); 2022 Aug; 8(9):. PubMed ID: 36135619
    [TBL] [Abstract][Full Text] [Related]  

  • 123. COVID-19 Associated Pulmonary Aspergillosis: A Case Series.
    Yulianti M; Johan C; Tenda ED; Singh G; Herikurniawan H; Wijaya IPEK
    Acta Med Indones; 2022 Apr; 54(2):292-298. PubMed ID: 35818652
    [TBL] [Abstract][Full Text] [Related]  

  • 124. Posaconazole for primary antifungal prophylaxis in patients with acute myeloid leukaemia or myelodysplastic syndrome during remission induction chemotherapy: a single-centre retrospective study in Korea and clinical considerations.
    Cho SY; Lee DG; Choi SM; Choi JK; Lee HJ; Kim SH; Park SH; Choi JH; Yoo JH; Kim YJ; Kim HJ; Min WS
    Mycoses; 2015 Sep; 58(9):565-71. PubMed ID: 26214656
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Putative invasive pulmonary aspergillosis in critically ill patients with chronic obstructive pulmonary disease: a matched cohort study.
    Delsuc C; Cottereau A; Frealle E; Bienvenu AL; Dessein R; Jarraud S; Dumitrescu O; Le Maréchal M; Wallet F; Friggeri A; Argaud L; Rimmelé T; Nseir S; Ader F
    Crit Care; 2015 Dec; 19():421. PubMed ID: 26631029
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Coronavirus Disease 2019-Associated Pulmonary Aspergillosis: Reframing the Debate.
    Clancy CJ; Nguyen MH
    Open Forum Infect Dis; 2022 May; 9(5):ofac081. PubMed ID: 35386295
    [TBL] [Abstract][Full Text] [Related]  

  • 127. Fungal Infections in the ICU during the COVID-19 Pandemic in Mexico.
    Roman-Montes CM; Bojorges-Aguilar S; Corral-Herrera EA; Rangel-Cordero A; Díaz-Lomelí P; Cervantes-Sanchez A; Martinez-Guerra BA; Rajme-López S; Tamez-Torres KM; Martínez-Gamboa RA; González-Lara MF; Ponce-de-Leon A; Sifuentes-Osornio J
    J Fungi (Basel); 2023 May; 9(5):. PubMed ID: 37233294
    [No Abstract]   [Full Text] [Related]  

  • 128. COVID-19-associated pulmonary aspergillosis in a tertiary care center in Shenzhen City.
    Jiang Z; Chen S; Zhu Q; Xiao Y; Qu J
    J Infect Public Health; 2022 Feb; 15(2):222-227. PubMed ID: 35032951
    [TBL] [Abstract][Full Text] [Related]  

  • 129. COVID-19-Associated Pulmonary Aspergillosis in Intensive Care Unit Patients from Poland.
    Skóra M; Gajda M; Namysł M; Wordliczek J; Zorska J; Piekiełko P; Żółtowska B; Krzyściak P; Heczko PB; Wójkowska-Mach J
    J Fungi (Basel); 2023 Jun; 9(6):. PubMed ID: 37367602
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Assessing the safety profile of voriconazole use in suspected COVID-19-associated pulmonary aspergillosis-a two-centre observational study.
    Costa-Pinto R; Klink S; Rotherham H; Perera P; Finlay L; Urbancic K; Vaz K; Trubiano J; Bellomo R
    Med Mycol; 2023 Jun; 61(6):. PubMed ID: 37286877
    [TBL] [Abstract][Full Text] [Related]  

  • 131. COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis.
    Huang SF; Ying-Jung Wu A; Shin-Jung Lee S; Huang YS; Lee CY; Yang TL; Wang HW; Chen HJ; Chen YC; Ho TS; Kuo CF; Lin YT;
    J Microbiol Immunol Infect; 2023 Jun; 56(3):442-454. PubMed ID: 36586744
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions.
    Egger M; Bussini L; Hoenigl M; Bartoletti M
    J Fungi (Basel); 2022 Apr; 8(4):. PubMed ID: 35448621
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry.
    Pagano L; Caira M; Candoni A; Aversa F; Castagnola C; Caramatti C; Cattaneo C; Delia M; De Paolis MR; Di Blasi R; Di Caprio L; Fanci R; Garzia M; Martino B; Melillo L; Mitra ME; Nadali G; Nosari A; Picardi M; Potenza L; Salutari P; Trecarichi EM; Tumbarello M; Verga L; Vianelli N; Busca A;
    Clin Infect Dis; 2012 Dec; 55(11):1515-21. PubMed ID: 22955439
    [TBL] [Abstract][Full Text] [Related]  

  • 134. Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave-A Single Center Experience.
    Dubler S; Turan ÖC; Schmidt KD; Rath PM; Verhasselt HL; Maier S; Skarabis A; Brenner T; Herbstreit F
    Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553055
    [TBL] [Abstract][Full Text] [Related]  

  • 135. Clinical efficacy and safety of primary antifungal prophylaxis with posaconazole versus fluconazole in allogeneic blood hematopoietic stem cell transplantation recipients-A retrospective analysis of a single medical center in Taiwan.
    Wang CH; Kan LP; Lin HA; Chang FY; Wang NC; Lin TY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):531-8. PubMed ID: 25440977
    [TBL] [Abstract][Full Text] [Related]  

  • 136. Invasive fungal infections in critically ill COVID-19 patients in a large tertiary university hospital in Israel.
    Ayalon O; Cohen MJ; Orenbuch-Harroch E; Sviri S; van Heerden PV; Korem M
    J Crit Care; 2022 Jun; 69():154004. PubMed ID: 35152143
    [TBL] [Abstract][Full Text] [Related]  

  • 137. Autopsy Findings of Severe COVID-19 Pneumonia Combined with Pulmonary Aspergillosis, Pneumothorax, and Pulmonary Thromboembolisms.
    Kanaji N; Kimura N; Kondo A; Watanabe N; Inoue T; Mizoguchi H; Komori Y; Kawada K; Kadowaki N
    Am J Case Rep; 2023 May; 24():e939251. PubMed ID: 37221822
    [TBL] [Abstract][Full Text] [Related]  

  • 138. Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
    Reizine F; Pinceaux K; Lederlin M; Autier B; Guegan H; Gacouin A; Luque-Paz D; Boglione-Kerrien C; Bacle A; Le Daré B; Launey Y; Lesouhaitier M; Painvin B; Camus C; Mansour A; Robert-Gangneux F; Belaz S; Le Tulzo Y; Tadié JM; Maamar A; Gangneux JP
    J Fungi (Basel); 2021 May; 7(5):. PubMed ID: 34063556
    [TBL] [Abstract][Full Text] [Related]  

  • 139. Antifungal agents for preventing fungal infections in non-neutropenic critically ill and surgical patients: systematic review and meta-analysis of randomized clinical trials.
    Playford EG; Webster AC; Sorrell TC; Craig JC
    J Antimicrob Chemother; 2006 Apr; 57(4):628-38. PubMed ID: 16459344
    [TBL] [Abstract][Full Text] [Related]  

  • 140. Intensive care management of influenza-associated pulmonary aspergillosis.
    Koehler P; Bassetti M; Kochanek M; Shimabukuro-Vornhagen A; Cornely OA
    Clin Microbiol Infect; 2019 Dec; 25(12):1501-1509. PubMed ID: 31102782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.